Dealing with a new diagnosis or confusing lab numbers? Talk with people who have been there. Compare real-world patient outcomes, lab numbers, and doctor visit tips—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Gut, Labs & Supplements Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Gut, Labs & Supplements Space →
Last Updated: Nov 22, 2026· Fact-Checked Primary Federal Data
← All Conditions (3,135) / Asthma, COPD & Respiratory Disease

Asthma, COPD & Respiratory Disease (104 Condition Guides)

Asthma, chronic obstructive pulmonary disease (COPD), pulmonary fibrosis, and airway inflammation.

Interactive MyChart Lab & Cuff Translator • Lab Bell-Curve “Normal” vs. Physiological Optimal

Why Your Portal Says “Normal” When You Still Feel Awful: Enter Your Number

Quest and LabCorp “Normal” ranges are 95% population bell curves—not physiological optimums. Select a marker and type your result below:

3-Zone Clinical Cutoff Audit • Serum Ferritin (Iron Storage)

18 ng/mL = Marked "Normal" by Lab, Yet Clinically Depleted (< 30–50 ng/mL)

Default Sample: 18 ng/mL
Zone 1 • Clinical Cutoff
< 15 ng/mL • Overt Deficiency
< 15 ng/mL (Absolute Depletion)
Zone 2 • Portal “Normal” Gray Zone
15–49 ng/mL • "Normal" Yet Depleted
15–150 ng/mL (Quest/LabCorp Bell Curve)
Zone 3 • Physiological Optimal
50–100 ng/mL • Clinical Optimal
50–100 ng/mL (Physiological Optimal)
What This Number Means in Plain English

Commercial labs only flag Ferritin below 15 ng/mL, but clinical trials confirm fatigue, restless legs, diffuse telogen hair shedding, and impaired T4-to-T3 thyroid conversion begin whenever Ferritin drops below 30–50 ng/mL.

Action Plan: Take 25–28 mg elemental Iron Bisglycinate on alternate mornings (Mon/Wed/Fri) with Vitamin C to bypass the 24-hour hepcidin block, then re-test in 8–12 weeks.

⚠ Lab Assay & Cuff False-Alarm Check

Acute inflammation, viral illness, or fatty liver artificially elevates Ferritin (it is an acute-phase reactant). Always pair Ferritin with Fasting Transferrin Saturation (TSAT) and hs-CRP.

Specialty Directory

Asthma, COPD & Respiratory Disease Guides (104)

Clear Filter × Page 1 of 3

Asthma (Bronchial Hyperresponsiveness)

Also called: Bronchial Asthma • Allergic & Exercise-Induced Asthma • Reactive Airway Disease

Characterized by reversible airway inflammation and bronchospasm confirmed by a >12% (and 200 mL) FEV1 improvement on spirometry. Modern GINA guidelines recommend anti-inflammatory inhaled corticosteroid + formoterol (SMART therapy) rather than relying on albuterol-only rescue inhalers.

First-Line Fix: GINA Track 1: Low-dose Inhaled Corticosteroid (ICS) + Formoterol inhaler (SMART therapy—treats inflammation + rescue in one)

Chronic Obstructive Pulmonary Disease (COPD)

Also called: COPD • Chronic Bronchitis • Emphysema

Confirmed by post-bronchodilator spirometry showing an FEV1/FVC ratio < 0.70 with chronic shortness of breath, cough, or wheezing. Smoking cessation, pulmonary rehabilitation, and modern dual LAMA/LABA maintenance inhalers significantly improve exercise capacity and cut flare-ups.

First-Line Fix: Smoking cessation + Dual LAMA/LABA bronchodilator inhaler (Umeclidinium/Vilanterol or Tiotropium/Olodaterol) + Pulmonary Rehab

Abscess

An abscess is a pocket of pus. You can get an abscess almost anywhere in your body. When an area of your body becomes infected, your body's immune system tries to fight the infection. White blood cells go to the infected area, collect within the damaged tissue, and cause inflammation. During this process, pus forms. Pus is a mixture of living and dead white blood cells, germs, and dead tissue. Bacteria, viruses, parasites and swallowed objects can all lead to abscesses. Skin abscesses are easy to detect. They are red, raised and painful. Abscesses inside your body may not be obvious and can damage organs, including the brain, lungs and others.

First-Line Fix: Fragrance-free ceramide barrier repair + targeted topical retinoid, anti-inflammatory, or antimicrobial regimen

Acute Bronchitis

Also called: Chest cold

Bronchitis is an inflammation of the bronchial tubes, the airways that carry air to your lungs. It causes a cough that often brings up mucus. It can also cause shortness of breath, wheezing, a low fever, and chest tightness. There are two main types of bronchitis: acute and chronic. Most cases of acute bronchitis get better within several days. But your cough can last for several weeks after the infection is gone. The same viruses that cause colds and the flu often cause acute bronchitis. These viruses spread through the air when people cough, or through physical contact (for example, on unwashed hands).

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Adult pulmonary Langerhans cell histiocytosis

Adult pulmonary Langerhans cell histiocytosis—coded clinically as J84.82 across Lungs & Asthma guidelines—combines high-resolution chest imaging in Adult pulmonary Langerhans cell histiocytosis (J84.82: when indicated) with structured follow-up of Spirometry FEV1 / in Adult pulmonary Langerhans cell histiocytosis (J84.82: FVC Ratio) (>= 0.75 (FEV1 >= 80% predicted) (J84.82)).

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Alpha-1 Antitrypsin Deficiency

Also called: AATD • Alpha-1 • Inherited emphysema

Alpha-1 antitrypsin deficiency (AAT deficiency, or AATD) is an inherited condition that raises your risk for lung and liver disease. If you have this condition, your body doesn't make enough alpha-1 antitrypsin (AAT). AAT is made by your liver. It helps protect your lungs from inflammation and irritating substances you might breathe in, such as smoke. If your liver doesn't make enough AAT, your lungs may be more easily damaged from smoking, pollution, or dust from the environment. This can lead to a serious lung condition called chronic obstructive pulmonary disease ( COPD ).

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Alveolar proteinosis

Designated in federal medical registries as J84.01, Alveolar proteinosis falls under Lungs & Asthma management, where lung diffusion capacity in Alveolar proteinosis (J84.01: (DLCO)) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Anthrax

Anthrax is a disease caused by Bacillus anthracis, a germ that lives in soil. Many people know about it from the 2001 bioterror attacks. In the attacks, someone purposely spread anthrax through the U.S. mail. This killed five people and made 22 sick. Anthrax is rare. It affects animals such as cattle, sheep, and goats more often than people. People can get anthrax from contact with infected animals, wool, meat, or hides. It can cause three forms of disease in people. They are: Cutaneous, which affects the skin. People with cuts or open sores can get it if they touch the bacteria. Inhalation, which affects the lungs.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Aspergillosis

Aspergillosis is a disease caused by a fungus (or mold) called Aspergillus. The fungus is very common in both indoors and outdoors. Most people breathe in the spores of the fungus every day without being affected. But some people get the disease. It usually occurs in people with lung diseases or weakened immune systems. There are different kinds of aspergillosis. One kind is allergic bronchopulmonary aspergillosis (also called ABPA). Symptoms of ABPA include wheezing and coughing. ABPA can affect healthy people but it is most common in people with asthma or cystic fibrosis. Another kind is invasive aspergillosis, which damages tissues in the body.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Atelectasis

Designated in federal medical registries as J98.11, Atelectasis falls under Lungs & Asthma management, where vaccination review [Atelectasis J98.11] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Berylliosis

Berylliosis (ICD-10-CM J63.2) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Breathing Problems

Also called: Respiratory • Respiration • Breath

When you're short of breath, it's hard or uncomfortable for you to take in the oxygen your body needs. You may feel as if you're not getting enough air. Sometimes you can have mild breathing problems because of a stuffy nose or intense exercise. But shortness of breath can also be a sign of a serious disease.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Bronchial Disorders

When you breathe in, the air travels down through your trachea (windpipe). It then goes through two tubes to your lungs. These tubes are your bronchi. Bronchial disorders can make it hard for you to breathe. The most common problem with the bronchi is bronchitis, an inflammation of the tubes. It can be acute or chronic.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchial obstruction

Also called: Bronchus • Bronchial • Bronchi

Bronchial obstruction—coded clinically as J98.09 across Lungs & Asthma guidelines—combines high-resolution chest imaging in Bronchial obstruction (J98.09: when indicated) with structured follow-up of Resting Pulse Oximetry in Bronchial obstruction (J98.09: (SpO2)) (96% – 100% (J98.09)).

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchiectasis

Bronchiectasis (ICD-10-CM J47.9) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchiectasis with (acute) exacerbation

Bronchiectasis with (acute) exacerbation (ICD-10-CM J47.1) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchiectasis with acute lower respiratory infection

Bronchiectasis with acute lower respiratory infection (ICD-10-CM J47.0) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchiolitis

Bronchiolitis (ICD-10-CM J21.9) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchitis

Bronchitis (ICD-10-CM J40) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchitis - acute

Bronchitis - acute (ICD-10-CM J20.9) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchitis - chronic

Bronchitis - chronic (ICD-10-CM J42) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchitis, not specified as acute or chronic

Bronchitis, not specified as acute or chronic (ICD-10-CM J40) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Bronchopulmonary dysplasia (BPD)

Also called: Bronchopulmonary dysplasia

Bronchopulmonary dysplasia (BPD) (ICD-10-CM P27.1) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

COPD exacerbation

Also called: Chronic obstructive pulmonary disease exacerbation • Respiratory • Respiration

COPD exacerbation (ICD-10-CM J44.1) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Centrilobular emphysema

Centrilobular emphysema (ICD-10-CM J43.2) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chest Pain

Also called: Thorax

Having a pain in your chest can be scary. It does not always mean that you are having a heart attack. There can be many other causes, including: Other heart problems, such as angina Panic attacks Digestive problems, such as heartburn or esophagus disorders Sore muscles Lung diseases, such as pneumonia, pleurisy, or pulmonary embolism Costochondritis - an inflammation of joints in your chest Some of these problems can be serious. Get immediate medical care if you have chest pain that does not go away, crushing pain or pressure in the chest, or chest pain along with nausea, sweating, dizziness or shortness of breath. Treatment depends on the cause of the pain.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Chronic Bronchitis

Chronic bronchitis is a type of COPD (chronic obstructive pulmonary disease). COPD is a group of lung diseases that make it hard to breathe and get worse over time. The other main type of COPD is emphysema. Most people with COPD have both emphysema and chronic bronchitis, but how severe each type is can be different from person to person. Chronic bronchitis is inflammation (swelling) and irritation of the bronchial tubes. These tubes are the airways that carry air to and from the air sacs in your lungs. The irritation of the tubes causes mucus to build up.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chronic obstructive pulmonary disease

Designated in federal medical registries as J44.9, Chronic obstructive pulmonary disease falls under Lungs & Asthma management, where high-resolution chest imaging in Chronic obstructive pulmonary disease (J44.9: when indicated) establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Chronic obstructive pulmonary disease (COPD)

Also called: Chronic obstructive pulmonary disease • Respiratory • Respiration

Chronic obstructive pulmonary disease (COPD) (ICD-10-CM J44.9) is evaluated within Asthma, COPD & Respiratory Disease using targeted symptom history, diagnostic lab or imaging thresholds, and evidence-graded first-line therapy.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Cold and Cough Medicines

What are cold and cough medicines? Cold and cough medicines can help relieve symptoms of a common cold. The symptoms of a cold can include a sore throat, stuffy or runny nose, sneezing, and coughing. You don't usually need to treat a cold or the cough that it causes. You can't cure a cold, and antibiotics won't help you get better. But sometimes the symptoms can keep you awake or cause a lot of discomfort. In that case, cold and cough medicines can sometimes be helpful.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Collapsed Lung

A collapsed lung happens when air enters the pleural space, the area between the lung and the chest wall. If it is a total collapse, it is called pneumothorax. If only part of the lung is affected, it is called atelectasis. Causes of a collapsed lung include: Lung diseases such as pneumonia or lung cancer Being on a breathing machine Surgery on the chest or abdomen A blocked airway If only a small area of the lung is affected, you may not have symptoms. If a large area is affected, you may feel short of breath and have a rapid heart rate. A chest x-ray can tell if you have it. Treatment depends on the underlying cause.

First-Line Fix: Airway anti-inflammatory support, targeted bronchodilator or antimicrobial therapy, and trigger avoidance

Cough

Also called: Coughing • Tussive • Coughed

Coughing is a reflex that keeps your throat and airways clear. Although it can be annoying, coughing helps your body heal or protect itself. Coughs can be either acute or chronic. Acute coughs begin suddenly and usually last no more than 2 to 3 weeks. Acute coughs are the kind you most often get with a cold, flu, or acute bronchitis. Chronic coughs last longer than 2 to 3 weeks.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits

Coughing up blood

Also called: Hemoptysis

Designated in federal medical registries as R04.2, Coughing up blood falls under Lungs & Asthma management, where vaccination review [Coughing up blood R04.2] establishes baseline severity and rules out diagnostic mimics.

First-Line Fix: Evidence-based first-line medical therapy paired with targeted nutrition, sleep, and lifestyle habits
Connected Clinical Ecosystem • Medications, Supplements & Specialists

Go From Diagnosis to Treatment: Connected Flagship Guides

Prescription Medications (/meds)

FDA DailyMed & NADAC Cash Price Guides

Decode tablet imprints, IR vs. ER stomach side effects, Rule-of-6 dose response curves, and $3–$9 generic cash prices.

Dietary Supplements (/supplements)

NIH ODS & Elemental Label Math Guides

Separate human RCT outcomes from social media hype—with elemental vs. compound weight decoders and serum 25(OH)D targets.

Verified Specialists (/doctors)

GreatDoc™ Score & Zero-Wall Insurance Check

Compare U.S. specialists by real CMS Medicare Part B procedure volume, verified Google patient reviews, and accepted PPO/Medicare plans.

Primary-Source Clinical SummaryUpdated Nov 22, 2026 · 0% Sponsored Ads

Which diagnostic lab ranges and guidelines govern Asthma, COPD & Respiratory Disease (104 on dotMD.com?

dotMD.com maps Asthma, COPD & Respiratory Disease (104 against ADA, ACC/AHA, USPSTF, and Endocrine Society diagnostic criteria, contrasting broad 95% portal reference intervals with optimal clinical targets. Standard portals often delay preventive action by 12 to 36 months, whereas structured 3-zone lab tracking surfaces borderline shifts early with 0% ad clutter.

Condition Care PillarAuthoritative SourceKey Quantitative BenchmarkPatient Benefit
Diagnostic Lab CutoffsADA / ACC / Endocrine3-zone optimal vs. portal rangeFlags 12–36 mo early
First-Line EvidencePubMed Phase 3 TrialsARR, NNT & 5-year risk math315 conditions covered
Medication Cash CostsCMS NADAC Survey$1–$5/mo generic benchmarks8x–40x retail savings
Doctor Visit PrepdotMD Lab Reader3–6 tailored MD questions100% free & private

How should patients prepare lab numbers and questions for a Asthma, COPD & Respiratory Disease (104 visit?

dotMD.com recommends bringing 3 baseline lab panels (6 to 12 months apart), current medication and supplement doses in milligrams, and 3 targeted physician questions. Auditing treatment options by Absolute Risk Reduction (ARR) and Number Needed to Treat (NNT) clarifies real 5-year benefit in under 5 mins.

Explore Verified Federal Clinical Guides & Monographs

Explore Full Library →
Founding Household Charter Waiting List • $0 Due Today 1 Membership Covers Up to 4 Family Members ($99/Yr vs. $19.95/Mo Regular)

Stop Paying Retail Markups on What You Just Read About. Buy Directly at the Federal Wholesale Receipts on Our Screen.

Join the dotMD Wholesale Health Club™ for $99/year total (up to 4 family members) and unlock: (1) Unlimited $5-deductible 24/7 online doctor visits, (2) Unlimited generic prescriptions at Cost + 10% + $3.95 fill via Mark Cuban’s Cost Plus Drugs model, and (3) 50,000+ lab-verified supplements at Wholesale Cost + 10% + $3.95 fill.

Lock In $99/Yr Household Rate ($0 Today) No credit card required today • 100% Year-1 Savings Guarantee